Other states have passed laws regulating pharmacy reimbursements. Why not Maine?
prescription drugs
Oklahoma court overturns $465 million opioid ruling against Johnson & Johnson
The Oklahoma Supreme Court weighed whether the company’s marketing and sale of opioids created a public nuisance.
Democrats reach deal on lowering drug prices; Biden upbeat on Manchin
Democrats are looking to cap out-of-pocket Medicare drug costs at $2,000 and reduce the price of insulin, as part of President Biden’s $1.75 trillion domestic policy proposal.
Our View: Opioid settlement funds must address addiction crisis
Deals are being reached with the companies responsible for shipping habit-forming medications across the U.S., and the proceeds must be used wisely.
Commentary: The Alzheimer’s mistake by the FDA is already getting worse
Now drugmaker Eli Lilly is pushing forward with another unproven treatment on the basis of limited evidence.
Commentary: Medicare must study unproven, expensive Alzheimer’s drug
Taxpayers and patients cannot afford to pay a high price for a treatment not known to be effective.
Commentary: Generic prescriptions deliver savings for Maine patients
An op-ed and an editorial praising proposed state regulations overlook the fact that brand-name drugs are consistently more costly to Maine.
Another View: Alzheimer’s drug furor highlights U.S. health system’s failures
Is aducanumab a breakthrough or a boondoggle? U.S. health policy offers reason to worry.
Our View: Maine prescription drug bills offer relief to stressed families
The proposals would help limit the constant price increases, which cost Mainers in more ways than one.
Maine Voices: Legislators must take action to keep prescription drug prices in line
Lawmakers should not yield to intimidation from those who profit by jacking up prices on medicines Mainers need.